JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB233488

m6A DNA Methylation Assay Kit (Colorimetric)

Be the first to review this product! Submit a review

|

(2 Publications)

m6A DNA Methylation Assay Kit (Colorimetric)(ab233488) kit contains all reagents necessary for the quantification of m6A in DNA.

View Alternative Names

KIAA1752, FTO, Alpha-ketoglutarate-dependent dioxygenase FTO, Fat mass and obesity-associated protein, U6 small nuclear RNA (2'-O-methyladenosine-N(6)-)-demethylase FTO, U6 small nuclear RNA N(6)-methyladenosine-demethylase FTO, mRNA (2'-O-methyladenosine-N(6)-)-demethylase FTO, mRNA N(6)-methyladenosine demethylase FTO, tRNA N1-methyl adenine demethylase FTO, m6A(m)-demethylase FTO

2 Images
Functional Studies - m6A DNA Methylation Assay Kit (Colorimetric) (AB233488)
  • FuncS

Supplier Data

Functional Studies - m6A DNA Methylation Assay Kit (Colorimetric) (AB233488)

Example of a m6A standard curve.

m6A standard control was added into the assay wells at different concentrations and then measured with the m6A DNA Methylation ELISA Kit (Colorimetric) (ab233488).

Functional Studies - m6A DNA Methylation Assay Kit (Colorimetric) (AB233488)
  • FuncS

Supplier Data

Functional Studies - m6A DNA Methylation Assay Kit (Colorimetric) (AB233488)

Quantification of m 6A content of various human DNA samples with the m6A DNA Methylation ELISA Kit (Colorimetric) (ab233488).

Key facts

Detection method

Colorimetric

Sample types

DNA

Assay type

Quantitative

Assay Platform

Microplate reader

Product details

m6A DNA Methylation Assay Kit (Colorimetric)(ab233488) kit contains all reagents necessary for the quantification of m6A in DNA. In this assay, DNA is bound to strip wells using DNA high binding solution. m6A is detected using capture and detection antibodies. The detected signal is enhanced and then quantified colorimetrically by reading the absorbance in a microplate spectrophotometer. The amount of m6A is proportional to the OD intensity measured.

N 6 -methyladenosine (m6A) is the most common and abundant modification on RNA molecules present in eukaryotes. DNA m 6A is also identified in multicellular eukaryotes including Caenorhabditis elegans and Drosophila melanogaster, and furthermore identified in higher eukaryotes including plants, mouse and human cells. m6A plays crucial roles in regulating DNA replication, transposition, transcription, and cellular defense. In humans, the DNA m 6A modification is most likely catalyzed by a methyltransferase complex METTL3 and removed by the α-ketoglutarate (α-KG)- and Fe2+ -dependent dioxygenases such as ALKBH5 and TET-like enzymes. It was shown that METTL3 and α-KG /Fe2+ - dependent dioxygenases play important roles in many biological processes, ranging from development and metabolism to fertility.

The dynamic and reversible chemical m6A modification on DNA may also serve as a novel epigenetic marker of profound biological significance. Down-regulation of m 6A modification was first characterized in human cancer cells and tissues, relative to their normal controls. m 6A is found to be the most regulated DNA modification in cancers. In addition to the regulation in cancer cells, relative to the primary cell/tissues which contain quite low amounts of DNA m 6A (<0.001%), a hundreds-fold increase of m 6A modification was found for in vitro cultured human cells (0.03%-0.22%). Therefore, identifying m 6A DNA methylation levels and distribution on DNA could advance understanding of epigenetic regulation of biological process at the genomic level, and further provide useful information for improving diagnostics and therapeutics of disease.

What's included?

{ "values": { "1x96Tests": { "sellingSize": "1 x 96 Tests", "publicAssetCode":"ab233488-1x96Tests", "assetComponentDetails": [ { "size":"1 x 10 mL", "name":"Binding Solution", "number":"AB233488-CMP03" }, { "size":"1 x 10 µL", "name":"Enhancer Solution", "number":"AB233488-CMP09" }, { "size":"1 x 20 µL", "name":"Negative DNA Control, 100 µg/ml", "number":"AB233488-CMP07" }, { "size":"12 x 1 Unit", "name":"8-Well Assay Strips (With Frame)", "number":"AB233488-CMP01" }, { "size":"1 x 28 mL", "name":"10X Wash Buffer", "number":"AB233488-CMP02" }, { "size":"1 x 20 µL", "name":"Positive Control, 200 µg/ml containing m6A 1 µg/ml", "number":"AB233488-CMP08" }, { "size":"1 x 12 µL", "name":"Detection Antibody, 1000 X", "number":"AB233488-CMP05" }, { "size":"1 x 10 µL", "name":"Capture Antibody, 1000 X", "number":"AB233488-CMP04" }, { "size":"1 x 10 mL", "name":"Developer Solution", "number":"AB233488-CMP06" }, { "size":"1 x 10 mL", "name":"Stop Solution", "number":"AB233488-CMP10" } ] }, "1x48Tests": { "sellingSize": "1 x 48 Tests", "publicAssetCode":"ab233488-1x48Tests", "assetComponentDetails": [ { "size":"1 x 5 µL", "name":"Capture Antibody, 1000 X", "number":"AB233488-CMP04", "productcode":"" }, { "size":"1 x 10 µL", "name":"Positive Control, 200 µg/ml containing m6A 1 µg/ml", "number":"AB233488-CMP08", "productcode":"" }, { "size":"1 x 5 µL", "name":"Enhancer Solution", "number":"AB233488-CMP09", "productcode":"" }, { "size":"1 x 6 µL", "name":"Detection Antibody, 1000 X", "number":"AB233488-CMP05", "productcode":"" }, { "size":"1 x 10 µL", "name":"Negative DNA Control, 100 µg/ml", "number":"AB233488-CMP07", "productcode":"" }, { "size":"1 x 14 mL", "name":"10X Wash Buffer", "number":"AB233488-CMP02", "productcode":"" }, { "size":"6 x 1 Unit", "name":"8-Well Assay Strips (With Frame)", "number":"AB233488-CMP01", "productcode":"" }, { "size":"1 x 5 mL", "name":"Binding Solution", "number":"AB233488-CMP03", "productcode":"" }, { "size":"1 x 5 mL", "name":"Developer Solution", "number":"AB233488-CMP06", "productcode":"" }, { "size":"1 x 5 mL", "name":"Stop Solution", "number":"AB233488-CMP10", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
Multi
Appropriate long-term storage conditions
Multi
Storage information
Please refer to protocols

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

M6A DNA methylation also known as N6-methyladenine modification involves the addition of a methyl group at the nitrogen-6 position of adenine within DNA strands. This modification mainly occurs in the eukaryotic genome and plays roles in gene expression regulation. The exact mass of m6A itself cannot be specified as it is a chemical modification rather than a separate protein. m6A methylation events are observed in various organisms including humans mice and plants suggesting its evolutionary significance across different species.
Biological function summary

The m6A modification of DNA affects transcriptional activity by influencing the interaction between DNA and proteins. This type of methylation acts similarly to a switch turning gene expression on or off as needed. In several cases m6A works closely within complexes involving RNA-binding proteins and transcription factors coordinating the stability splicing and translation of mRNAs. This suggests a significant role in post-transcriptional gene regulation. For instance components such as METTL3 and METTL14 are associated with m6A methylation and contribute to forming a complex that performs these regulatory functions.

Pathways

The modification by m6A DNA methylation appears to be an integral part of epigenetic pathways that govern cellular differentiation and development. It also influences the methylation signaling pathway aiding in the fine-tuning of epigenetic states within the cell. Proteins related to m6A-modified pathways include ALKBH5 and FTO both of which demethylate m6A marks allowing dynamic control of DNA interpretation. Understanding these modifications within pathways requires considering how they affect gene regulatory networks on an epigenetic level.

Altered m6A DNA methylation patterns have been linked to various cancers and neurological disorders. Dysregulation of m6A has been observed in cancers such as acute myeloid leukemia where it is implicated in the proliferation and differentiation of malignant cells. The proteins METTL3 and FTO play roles in cancer progression making them targets for therapeutic intervention. In neurological disorders defective m6A methylation has associations with autism spectrum disorder where it affects neural development and brain function. The modification's regulatory impact on neurodevelopmental genes highlights its potential involvement in these conditions.

Product protocols

Target data

RNA demethylase that mediates oxidative demethylation of different RNA species, such as mRNAs, tRNAs and snRNAs, and acts as a regulator of fat mass, adipogenesis and energy homeostasis (PubMed : 22002720, PubMed : 25452335, PubMed : 26457839, PubMed : 26458103, PubMed : 28002401, PubMed : 30197295). Specifically demethylates N(6)-methyladenosine (m6A) RNA, the most prevalent internal modification of messenger RNA (mRNA) in higher eukaryotes (PubMed : 22002720, PubMed : 25452335, PubMed : 26457839, PubMed : 26458103, PubMed : 30197295). M6A demethylation by FTO affects mRNA expression and stability (PubMed : 30197295). Also able to demethylate m6A in U6 small nuclear RNA (snRNA) (PubMed : 30197295). Mediates demethylation of N(6),2'-O-dimethyladenosine cap (m6A(m)), by demethylating the N(6)-methyladenosine at the second transcribed position of mRNAs and U6 snRNA (PubMed : 28002401, PubMed : 30197295). Demethylation of m6A(m) in the 5'-cap by FTO affects mRNA stability by promoting susceptibility to decapping (PubMed : 28002401). Also acts as a tRNA demethylase by removing N(1)-methyladenine from various tRNAs (PubMed : 30197295). Has no activity towards 1-methylguanine (PubMed : 20376003). Has no detectable activity towards double-stranded DNA (PubMed : 20376003). Also able to repair alkylated DNA and RNA by oxidative demethylation : demethylates single-stranded RNA containing 3-methyluracil, single-stranded DNA containing 3-methylthymine and has low demethylase activity towards single-stranded DNA containing 1-methyladenine or 3-methylcytosine (PubMed : 18775698, PubMed : 20376003). Ability to repair alkylated DNA and RNA is however unsure in vivo (PubMed : 18775698, PubMed : 20376003). Involved in the regulation of fat mass, adipogenesis and body weight, thereby contributing to the regulation of body size and body fat accumulation (PubMed : 18775698, PubMed : 20376003). Involved in the regulation of thermogenesis and the control of adipocyte differentiation into brown or white fat cells (PubMed : 26287746). Regulates activity of the dopaminergic midbrain circuitry via its ability to demethylate m6A in mRNAs (By similarity). Plays an oncogenic role in a number of acute myeloid leukemias by enhancing leukemic oncogene-mediated cell transformation : acts by mediating m6A demethylation of target transcripts such as MYC, CEBPA, ASB2 and RARA, leading to promote their expression (PubMed : 28017614, PubMed : 29249359).
See full target information FTO

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Nanomaterials (Basel, Switzerland) 11: PubMed34835707

2021

The Mechanosensing and Global DNA Methylation of Human Osteoblasts on MEW Fibers.

Applications

Unspecified application

Species

Unspecified reactive species

Pingping Han,Cedryck Vaquette,Abdalla Abdal-Hay,Sašo Ivanovski

International journal of molecular sciences 22: PubMed33670900

2021

Salivary Outer Membrane Vesicles and DNA Methylation of Small Extracellular Vesicles as Biomarkers for Periodontal Status: A Pilot Study.

Applications

Unspecified application

Species

Unspecified reactive species

Pingping Han,Peter Mark Bartold,Carlos Salomon,Sašo Ivanovski
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com